SCHEMBL7164530

SCHEMBL7164530

CN1OCC(=O)N(c2ccc(Oc3ccccc3)cc2)C1=S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 2/20 0.48
▸ PLCG1 P19174 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ GAA P10253 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ FAAH O00519 1/20 0.39
▸ NTRK1 P04629 1/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ NTRK3 Q16288 1/20 0.38
▸ NTRK2 Q16620 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MMP2 P08253 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7164121 0.76 KMT2A (0.39) ALDH1A1ALOX15MAPTPOLBLMNA
SCHEMBL5955129 0.74 PLCG1 (0.55) MGLLPLCG1ALDH1A1ALOX15USP2
SCHEMBL17281692 0.71 MGLL (0.65) MGLLPLCG1ALDH1A1ALOX15USP2
SCHEMBL7163494 0.70 NOX4 (0.45) ALDH1A1MAPTPOLBGAAMEN1
SCHEMBL5301085 0.70 MGLL (0.54) MGLLPLCG1ALDH1A1ALOX15USP2
SCHEMBL7164266 0.69 FAAH (0.49) MGLLALDH1A1ALOX15MAPTFAAH
SCHEMBL5955006 0.67 MGLL (0.50) MGLLPLCG1ALDH1A1ALOX15USP2
SCHEMBL5293066 0.66 MGLL (0.57) MGLLPLCG1ALDH1A1ALOX15USP2
SCHEMBL7162436 0.66 MAPT (0.37) ALDH1A1MAPTLMNAGAANPSR1
SCHEMBL5954387 0.66 MGLL (0.49) MGLLPLCG1ALDH1A1ALOX15MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562814-B2 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives WYETH 2003-05-13 — — US claimed
US-20020061883-A1 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives AMERICAN HOME PRODUCTS CORPORATION 2002-05-23 — — US claimed
WO-2002028845-A1 3-THIOXO-[1,2,4]-OXADIAZINAN-5-ONE AND THEIR USE AS ANTI-ANTHEROSCLEROTIC AGENTS WYETH (US) 2002-04-11 — — WO claimed
US-6562814-B2 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives WYETH 2003-05-13 — — US disclosed
US-20020061883-A1 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives AMERICAN HOME PRODUCTS CORPORATION 2002-05-23 — — US disclosed
WO-2002028845-A1 3-THIOXO-[1,2,4]-OXADIAZINAN-5-ONE AND THEIR USE AS ANTI-ANTHEROSCLEROTIC AGENTS WYETH (US) 2002-04-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061883-A1 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives AHR, PAOX, PPARA MGLL 1703/4885PLCG1 581/4885ALDH1A1 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback